Inborn Errors of Metabolism: Clinical Trials

1 trial for Inborn Errors of Metabolism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1
Phase 31Unknown 1

Follow Inborn Errors of Metabolism: new trials by email Literature Review of Inborn Errors of Metabolism trials Research Report on Inborn Errors of Metabolism

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
N-Carbamylglutamate (Carbaglu) In The Treatment Of Hyperammonemia
N-carbamylglutamate - Inborn Errors of Metabolism
Phase 2 / Phase 3UnknownMendel Tuchman522008-08-012020-02-17

Narrower conditions

Hyperammonemia (1)  ·  Metabolism, Inborn Errors (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

N-carbamylglutamate (1)  ·  carglumic acid (1)

Sponsors

Mendel Tuchman (1)

Countries

United States (1)

Top investigators

Mendel Tuchman, MD (1)

NIH funding

R01HD058567 (1)